* Represents mandatory fields
Measles is a highly contagious, serious disease caused by a virus. In 1980, before widespread vaccination, measles caused an estimated 2.6 million deaths globally each year.
The disease remains one of the leading causes of death among young children globally, despite the availability of a safe and effective vaccine. Approximately 134,200 people died from measles in 2015 – mostly children under the age of 5.
Measles is caused by a virus in the paramyxovirus family and it is normally passed through direct contact and through the air. The virus infects the respiratory tract, then spreads throughout the body. Measles is a human disease and is not known to occur in animals.
Accelerated immunization activities have had a major impact on reducing measles deaths. During 2000-2015, measles vaccination prevented an estimated 20.3 million deaths. Global measles deaths have decreased by 79% from an estimated 651 600 in 2000* to 134 200 in 2015.
Signs and Symptoms
These consists initially of:
After several days,
The most serious complications include:
Complications are more common in children under the age of 5, or adults over the age of 20. Severe measles is more likely among poorly nourished young children, especially those with insufficient vitamin A, or whose immune systems have been weakened by HIV/AIDS or other diseases.
Most measles-related deaths are caused by complications associated with the disease
In populations with high levels of malnutrition and a lack of adequate health care, up to 10% of measles cases result in death. Women infected while pregnant are also at risk of severe complications and the pregnancy may end in miscarriage or preterm delivery. People who recover from measles are immune for the rest of their lives.
Who is at risk for measles?
Measles is still common in many developing countries – particularly in parts of Africa and Asia.
The overwhelming majority (more than 95%) of measles deaths occur in countries with low per capita incomes and weak health infrastructures.
Measles outbreaks can be particularly deadly in countries experiencing or recovering from a natural disaster or conflict. In such situations, damage to health infrastructure and health services interrupts routine immunization, and overcrowding in residential camps greatly increases the risk of infection.
How is measles transmitted?
Measles can be transmitted by an infected person from 4 days prior to the onset of the rash to 4 days after the rash erupts.
The highly contagious virus is spread by:
The virus remains active and contagious in the air or on infected surfaces for up to 2 hours.
Measles outbreaks can result in epidemics that cause many deaths, especially among young, malnourished children.
In countries where measles has been largely eliminated, cases imported from other countries remain an important source of infection.
Treatment of measles
There is no specific antiviral treatment for measles virus.
Supportive care of severe complications from measles is the main stay of measles treatment.
The supportive care includes:
Routine measles vaccination for children, combined with mass immunization campaigns in countries with high case and death rates, are key public health strategies to reduce global measles deaths.
The measles vaccine has been in use for over 50 years. It is safe, effective and inexpensive.
In South Africa, the recommended routine immunization schedule for measles is for the first dose to be given at 9 months after birth and the second dose at 12 months.
The measles vaccine is often incorporated with rubella and/or mumps vaccines in countries where these illnesses are problems. It is equally effective in the single or combined form.
In 2015, about 85% of the world's children received 1 dose of measles vaccine by their first birthday through routine health services – up from 73% in 2000. Two doses of the vaccine are recommended to ensure immunity and prevent outbreaks, as about 15% of vaccinated children fail to develop immunity from the first dose.
Measles is a highly contagious infection caused by the measles virus. It commonly afflicts non-immunied children but immuno-compromised or immune-suppressed adults may also be affected. Although the frequency of measles attack has been lowered considerably globally between 2005 - 2015 through immunisation, the condition still afflicts children especially in low income African and Asian countries. There is no specific treatrment for measles. it is cost-effectively prevented through routine immunisation.
Content adapted from: World Health Organisation – Measles
Related: Immunisation schedules - Africa
Posted: May 10, 2020